We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 353

Premature development causes unease in China

  • Shook Hardy & Bacon LLP
  • -
  • China, USA
  • -
  • August 20 2010

Chinese health experts have reportedly estimated that "at least 30,000 children developed early maturity" in Shanghai alone, raising concerns about food additives and pesticides allegedly laden with sex hormones

China to amend measures for foreign invested medical institutions

  • Orrick Herrington & Sutcliffe LLP
  • -
  • China
  • -
  • April 27 2012

On April 13, 2012, the Ministry of Health (“MOH”) published for public comment a draft version of the Measures for the Administration of Sino-foreign Equity and Cooperative Medical Institutions

China agencies drafting policies to accelerate development of medical devices, supporting fund to be introduced in July (Shanghai Securities News 2012-07-05) --- July 5, 2012)

  • Reed Smith LLP
  • -
  • China
  • -
  • August 8 2012

The medical device industry constitutes a major part of China’s strategic growth industries

More certainty, less discretion proposed new rules on administrative penalty over drug and medical equipment industry

  • King & Wood Mallesons
  • -
  • China
  • -
  • May 10 2013

On 19 September 2012, SFDA released the Rules on Imposing Administrative Penalties for Drugs and Medical Equipment (Consultative Draft) (the "Draft"

China SAIC launches three-month campaign against unfair competition practices with emphasis on healthcare sector

  • Sidley Austin LLP
  • -
  • China
  • -
  • August 21 2013

In mid-August 2013, China's State Administration for Industry and Commerce ("SAIC") announced a three-month nationwide campaign against unfair

China updates blacklist system to combat commercial bribery in health care

  • HaoLiWen
  • -
  • China
  • -
  • February 7 2014

Recently, the China National Health and Family Planning Commission ( the "Commission") issued the Rules on Establishing Commercial Bribery Blacklists

Chinese FDA imposes mandatory electronic barcoding on imported drugs

  • Ropes & Gray LLP
  • -
  • China
  • -
  • February 5 2013

The State Food and Drug Administration ("SFDA") issued a Notice on Relevant Issues Concerning Imposing Electronic Barcoding on Imported Drugs

China issues Hospital Complaint Rules (for Trial Implementation)

  • Sheppard Mullin Richter & Hampton LLP
  • -
  • China
  • -
  • December 15 2009

The Chinese Ministry of Health ("MOH") announced the promulgation of the Hospital Complaint Rules (for Trial Implementation) (the "Rules") on November 26, 2009

MOH circulates the administrative measures on health card for residents (for trial implementation)

  • Reed Smith LLP
  • -
  • China
  • -
  • March 13 2012

According to the Notice issued by the MOH on December 30, 2011, domestic residents may apply for the resident health cards in certain qualified areas and use them in any medical institutions

SFDA opens special approval channel for the registration of certain new drugs

  • Hogan Lovells
  • -
  • China
  • -
  • February 24 2009

On January 7, 2009, the State Food and Drug Administration of the PRC (SFDA) issued the Provisions on Special Approval for the Registration of New Drugs